COVID-19 UPDATES
**This information will be updated frequently as guidelines from the CDC and Department of Health Change**
Melrose Pharmacy is providing the Moderna COVID-19 Vaccines to individuals 18 years and older.
We are currently scheduling third dose and booster dose appointments for eligiblae patients. Please see requirements below.
THIRD/BOOSTER DOSE COVID-19 VACCINE INFORMATION
Who is eligible & recommended to receive a third dose of the COVID-19 vaccine?
Moderately to severely immunocompromised patients are now recommended to receive a third dose of the Pfizer or Moderna vaccine at least 28 days after the completion of their initial mRNA COVID-19 vaccine series. Please note, this is not a booster and only applies to immunocompromised patients.
-
Be 18 years or older -
Be moderately to severely immunocompromised including: -
Receiving active cancer treatment for tumors or cancers of the blood -
Received an organ transplant and am taking medicine to suppress the immune system -
Received a stem cell transplant within the last 2 years or am taking medicine to suppress the immune system -
Have moderate or severe primary immunodeficiency (such as DiGeorge syndrome, Wiskott-Aldrich syndrome) -
Have advanced or untreated HIV infection -
Have active treatment with high-dose corticosteroids or other drugs that may suppress my immune response
-
Who is eligible & recommended to receive a booster dose of the COVID-19 vaccine?
A booster dose is recommended at least 6 months after the date of the second dose of Pfizer or Moderna, or 2 months if you received Janssen first dose. You may receive Moderna booster dose no matter what brand you received for the first and second dose.
-
Adults aged 65 or older -
Adults 50 to 64 with an underlying medical condition -
Adults 18 to 49 with an underlying medical condition, and feel the need for an additional dose based off individual benefits and risks -
Adults 18 to 64 at an increased risk of COVID-19 exposure and transmission because of occupational or instituional settings -
Adults 18 to 64 who received Janssen (J&J) for their first dose
To learn more about the Moderna COVID-19 Vaccine click here to read the Emergency Use Authorization (EUA).